Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-26 Sale |
2024-09-30 4:32 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
847 | $16 | $13,552 | 125,149 (Direct) |
View |
| 2024-09-06 Sale |
2024-09-10 4:33 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
2,303 | $15.09 | $34,753 | 125,996 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 4:33 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
27,097 | $16.27 | $440,801 | 194,938 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 4:34 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
1,826 | $12.32 | $22,499 | 137,204 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-06 5:07 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
972 | $13.47 | $13,089 | 69,668 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-12 4:33 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
7,097 | $18.03 | $127,938 | 35,376 (Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 4:46 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
15,982 | $15.42 | $246,403 | 42,473 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 4:54 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
2,100 | $24.05 | $50,495 | 45,283 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:48 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
9,348 | $20.77 | $194,191 | 47,383 (Direct) |
View |
| 2022-10-20 Sale |
2022-10-24 5:13 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
6,080 | $18.66 | $113,426 | 56,731 (Direct) |
View |
| 2022-09-26 Sale |
2022-09-28 5:08 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,544 | $15.45 | $23,854 | 62,811 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:55 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
4,293 | $15.11 | $64,878 | 64,355 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:34 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
100 | $15.01 | $1,501 | 68,648 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:14 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,777 | $15.11 | $26,845 | 68,748 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:02 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
7,714 | $13 | $100,282 | 64,893 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Tax Withholding |
2025-03-04 4:59 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
5,144 | $11.68 | 271,605 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 4:59 pm |
N/A 2035-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
151,600 | $0 | 271,605 (Direct) |
View |
| 2024-09-04 Tax Withholding |
2024-09-05 6:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
983 | $15.42 | 128,299 (Direct) |
View |
| 2024-09-05 Tax Withholding |
2024-09-05 6:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
171 | $15.13 | 128,299 (Direct) |
View |
| 2024-09-03 Tax Withholding |
2024-09-05 6:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
15 | $17.7 | 128,299 (Direct) |
View |
| 2024-09-03 Tax Withholding |
2024-09-05 6:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
156 | $16.93 | 128,299 (Direct) |
View |
| 2024-09-03 Tax Withholding |
2024-09-05 6:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
483 | $15.76 | 128,299 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 4:33 pm |
N/A 2029-12-10 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
20,000 | $0 | 194,938 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 4:33 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
20,000 | $1.74 | 194,938 (Direct) |
View |
| 2024-03-05 Tax Withholding |
2024-03-05 7:46 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
1,486 | $12.28 | 189,130 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:46 pm |
N/A 2034-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
143,200 | $0 | 189,130 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:46 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
409 | $13.37 | 189,130 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:46 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
343 | $12.42 | 189,130 (Direct) |
View |
| 2023-09-05 Tax Withholding |
2023-09-06 5:07 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
436 | $14.46 | 69,668 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:07 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
35,700 | $0 | 69,668 (Direct) |
View |
| 2023-03-01 Option Award(A) |
2023-04-19 5:46 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
35,700 | $0 | 79,955 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:33 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
71,400 | $0 | 115,655 (Direct) |
View |
| 2023-03-02 Tax Withholding |
2023-03-03 4:33 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,028 | $11.6 | 115,655 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
5,632 | $0 | 70,525 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:18 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
33,788 | $0 | 33,788 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:11 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
78,838 | $0 | 140,182 (Direct) |
View |
| 2021-10-28 Option Award |
2021-11-01 6:58 pm |
N/A 2031-10-28 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
95,148 | $0 | 95,148 (Direct) |
View |
Ownership |
2021-10-28 8:58 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
0 | $0 | 279,411 (Direct) |
View |